Furthermore, the actions of ER-subtype specific agonists on thyroid cancer cell lines have been studied in vitro: propyl-pyrazole-triol (PPT, ERα-specific) stimulated cell proliferation, while diarylpropionitrile (DPN, ERβ-specific) had an inhibitory effect [46]. Here, ESR1 is linked to thyroid gland carcinoma.